The clinical laboratory and dyslipidemia

Jesús Méndez González, Jesús Martín Campos, Jordi Ordóñez Llanos

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)


The prevalence of dyslipidemia (alterations in lipoprotein metabolism) as a risk factor for cardiovascular disease continues to rise. Determination of circulating levels of lipids, lipoproteins and related proteins allows the diagnosis, treatment and follow-up of the various types of dyslipidemia. However, numerous factors influence the concentration of these constituents in the circulation. These factors depend both on the individual (habits, physical characteristics, presence of other risk factors) and on the sample and analytical methods employed and must be taken into account when assessing and interpreting laboratory results. Similarly, the cause of the different forms of dyslipidemia may lie not only in environmental but also in genetic factors. Consequently, the inclusion of genetic tests in the diagnosis of dyslipidemia is increasingly frequent.
Original languageEnglish
Pages (from-to)89-96
JournalEndocrinologia y Nutricion
Issue number2
Publication statusPublished - 1 Feb 2008


  • Analytical variability
  • Biological variability
  • Clinical laboratory
  • Dyslipidemia
  • Genetics
  • Lipids
  • Preanalytical variability


Dive into the research topics of 'The clinical laboratory and dyslipidemia'. Together they form a unique fingerprint.

Cite this